Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

M Pai serves as a consultant to the Bill & Melinda Gates Foundation (BMGF), but the views expressed in this article are his own. He also receives grant funding (grant OPP1061487) from BMGF for projects to assess the TB diagnostics market size and develop TTPs for POC testing. C Denkinger is supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs – Wellcome Fund from the American Society of Tropical Medicine and Hygiene. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Notes

NAAT: Nucleic acid amplification test; TB: Tuberculosis.